Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 434, 1067 (28 April 2005) | doi:10.1038/4341067a; Published online 27 April 2005
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
.Net
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Postdoctoral Fellow / Research Associate
- Beth Israel Deaconess Medical Center/Harvard Medical School
- Boston, MA, USA
A drug is effective if better than a harmless control
Brooks Jackson1 & Thomas Fleming2
- Johns Hopkins School of Medicine, 600 North Wolfe Street, Baltimore, Maryland 21287, USA
- Department of Biostatistics, University of Washington, Box 357232, Seattle, Washington 98195, USA
Abstract
Valid trials can still be held, as with HIVNET 012, when ethics rules out a placebo group.
In his Correspondence letter "HIV drug remains unproven without placebo trial" (Nature 434, 137; 2005), Valendar Turner asks on what basis it can be claimed that the single-dose nevirapine regimen is effective in reducing mother-to-infant HIV transmission.He points out that the placebo arm was dropped in the HIVNET 012 trial (of which we were team members) and notes the high variability in reported historical HIV transmission rates.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
HIV denialists ignore large gap in the study they citeNature Correspondence (25 May 2006)
AIDS drug trials in Thailand and UgandaNature Medicine Letters to Editor (01 Nov 1999)
Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)Clinical Pharmacology & Therapeutics Article Response
HIV drug remains unproven without placebo trialNature Correspondence (10 Mar 2005)
See all 7 matches for Research